Skip to main content
Signal8

Nanobiotix S.A. (NBTX)

Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has established a strategic collaboration with LianBio for the development and commercialization of NBTXR3 within key Asian markets, specifically Greater China, South Korea, Singapore, and Thailand. Founded in 2003, the company's main operations are situated in Paris, France.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Nanobiotix S.A. logo

Nanobiotix S.A.

NASDAQ:NBTXHealthcare
-7.19%$31.37
AH$31.37+0.00%vs close
Mkt Cap$1.6B
Float47.78M
O/S50.95M
Vol
$ Vol
RVOL
Inst Own11.4%
SI0.4%
Earnings
Dilution
Financials Summary
Revenue$33.12M
Net Income-$26.77M
Total Assets$75.7M
Free Cash Flow-$37.95M
Debt & Equity
Debt 880%
Total Debt$106.49M
Total Equity-$94.38M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in NBTX's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$75.7M
Liabilities$170.09M
Accounts Receivable$8.58M
Accounts Payable$7.35M
Inventory$0
PP&E (Net)$5.1M
Goodwill$0
Intangible Assets$11K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$33.12M-$8.03M$40.45M$5.34M$2.96M$2.6M$2.84M$3.89M$4.16M$6.06M$4.49M$3.1M$1.78M$1.08M$1.52M
YoY Growth-512.3%-119.9%658.1%80.4%13.8%-8.5%-27.0%-6.5%-31.3%35.0%44.9%73.7%64.4%-28.6%-
Cost of Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Gross Profit$33.12M-$8.03M$40.45M$5.34M$2.96M$2.6M$2.84M$3.89M$4.16M$6.06M$4.49M$3.1M$1.78M$1.08M$1.52M
Gross Margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Research and Development$25.82M$45.29M$42.9M$36.46M$33.94M$27.18M$33.98M$23.34M$19.81M$18.9M$15.53M$9.02M$6.73M$4.82M$5.82M
Selling, General, and Administrative$22.59M$22.93M$24.63M$19.95M$21.71M$16.32M$21.13M$14.14M$12.57M$11.58M$8.11M$4.82M$4.19M$2.02M$1.45M
Other-$3.21M$150K$2.84M$1.1M$6.05M-$210K$0$0$1K$0$0$0$0$0$0
Total Operating Expenses$45.2M$68.37M$70.37M$57.51M$61.7M$43.29M$55.1M$37.48M$32.39M$30.47M$23.64M$13.84M$10.92M$6.87M$5.84M
Operating Income (EBIT)-$12.09M-$76.41M-$29.92M-$52.18M-$58.74M-$40.7M-$52.26M-$33.59M-$28.23M-$24.42M-$19.15M-$10.75M-$9.14M-$5.76M-$5.84M
Operating Margin-36.5%951.2%-74.0%-977.8%-1986.4%-1566.8%-1841.0%-864.2%-678.9%-403.1%-426.9%-347.2%-512.7%-530.9%-384.3%
Interest Expense$11.61M$9.03M$8.92M$6.52M$781K$372K$5.35M$946K$121K$114K$66K$62K$27K$86K$34K
Interest Income$1.1M$2.94M$1.36M$286K$0$0$117K$38K$37K$66K$205K$220K$66K$51$13K
Other Income (Expense)-$14.68M$403K-$14.3M-$11.54M$6.24M$3.18M-$4.62M-$311K-$979K$72K$155K$159K$39K-$111K-$22K
Income Before Tax (EBT)-$26.77M-$76M-$44.22M-$63.72M-$52.51M-$37.52M-$56.88M-$33.9M-$29.21M-$24.34M-$19M-$10.59M-$9.1M-$5.87M-$5.86M
Income Tax Expense$3K$113K$134K$11K$6K$10K$3K$0$0$101K$0$89K$0$88K$34K
Net Income-$26.77M-$76.12M-$44.35M-$63.73M-$52.51M-$37.53M-$56.88M-$33.9M-$29.21M-$24.44M-$19M-$10.68M-$9.1M-$5.96M-$5.86M
Net Income Margin-80.8%947.6%-109.6%-1194.3%-1775.7%-1444.7%-2003.7%-872.2%-702.4%-403.6%-423.5%-344.9%-510.5%-549.2%-385.7%
Supplementary Data
EPS-0.50-1.44-1.08-1.64-1.35-1.38-2.35-1.52-1.50-1.43-1.20-0.74-0.76-0.65-3.42
Diluted EPS-0.50-1.44-1.08-1.64-1.35-1.38-2.35-1.52-1.50-1.43-1.20-0.74-0.76-0.65-3.42
Weighted Average OS47.82M47.27M36.76M34.85M34.73M24.39M21.63M19.62M17.43M15.28M14.14M12.87M10.75M8.22M1.54M
EBITDA-$13.48M-$74.45M-$25.39M-$49.4M-$50.95M-$38.95M-$50.29M-$32.9M-$27.68M-$23.88M-$18.64M-$10.4M-$8.88M-$5.59M-$5.61M
EBITDA Margin-40.7%926.8%-62.8%-925.8%-1722.9%-1499.4%-1771.4%-846.5%-665.7%-394.2%-415.6%-336.1%-498.0%-515.8%-368.9%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$58.93M$55.57M$84.11M$46.24M$93.76M$133.12M$39.21M$40.45M$52.75M$23.53M$19M$36.85M$5.59M$13.81M$1M
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$58.93M$55.57M$84.11M$46.24M$94.03M$133.12M$39.21M$40.45M$52.75M$23.53M$19M$36.85M$5.59M$13.81M$1M
Accounts Receivable$8.58M$9.54M$3.31M$3.18M$4.35M$4.33M$1.4M$1.11M$943K$6K$790K$70K$69K$9K$1.5M
Inventory$0$0$223K$3.33M$0$0$2.98M$1.22M-$5.47M-$5.62M$1.35M$529K$223K-$1.2M$98K
Other Current Assets$2K-$1K$7.07M$2.42M$3.4M$0$4.95M$5.95M$5.28M$5.61M$5.2M$2.28M$1.89M$0$0
Total Current Assets$70.1M$68.67M$97.58M$58.49M$103.97M$139.93M$51.53M$47.65M$59.33M$30.04M$25.64M$39.67M$7.7M$15.13M$2.61M
Long-Term Assets
Property, Plant & Equipment Net$5.1M$6.19M$6.82M$7.95M$9.15M$9.22M$10.49M$3.22M$3.34M$2.72M$2.72M$1.44M$523K$465K$571K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$11K$8K$9K$1K$4K$23K$182K$114K$152K$5K$8K$11K$10K$0$7K
Long-Term Investments$0$0$0$0$109K$117K$146K$197K$305K$271K$244K$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$448K$446K$0$1.07M$932K$908K$0$0$0$0
Other Long-Term Assets$485K$454K$495K$325K$470K-$1K-$1K$427K$0$0$0$276K$76K$77K$71K
Total Long-Term Assets$5.6M$6.65M$7.33M$8.28M$9.73M$9.81M$11.26M$3.96M$4.87M$3.92M$3.88M$1.73M$609K$542K$648K
Other Assets$0$1K$0-$1K$0$0$0$0$0$0$0$0$0$0$2
Total Assets$75.7M$75.32M$104.9M$66.77M$113.7M$149.74M$62.79M$51.61M$64.2M$33.97M$29.51M$41.4M$8.31M$15.67M$3.25M
Liabilities
Current Liabilities
Accounts Payable$7.35M$5.01M$7.48M$4.47M$5.58M$6.23M$6.87M$5.07M$5.75M$4.89M$4.01M$2.5M$1.51M$312K$447K
Short-Term Debt$3.46M$4.09M$4.27M$4.02M$7.91M$4.11M$559K$559K$860K$1.21M$1.2M$359K$258K$403K$330K
Current Income Tax Payable$7.62M$7.68M$8.24M$7.37M$5.67M$316K$241K$201K$256K$189K$1.77M$96K$74K$40K$2K
Current Unearned Revenue$40.46M$20.29M$20.36M$18.52M$18.74M$0$7.94M$104K$3.31M$2.49M$2M$1.6M$1.16M$1.7M$804K
Other Current Liabilities$480K$9.24M$849K$365K$6.02M$7.89M-$7.48M$633K$902K$622K-$883K-$870K-$260K$645K$722K
Total Current Liabilities$64.25M$65.84M$55.72M$42.38M$41.16M$21.27M$16.03M$12.96M$10.45M$9.21M$7.93M$4.94M$3.67M$2.41M$1.58M
Long-Term Liabilities
Long-Term Debt$99.57M$48.05M$46.54M$49.2M$36.22M$43.7M$42.03M$22.37M$4.19M$5.12M$3.94M$2.24M$978K$1.2M$589K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$4.16M$31.51M$363K$302K$355K$463K$371K$373K$499K$196K$194K$349K$111K$107K$52K
Total Long-Term Liabilities$105.84M$82.88M$51.24M$54.61M$42.6M$49.74M$48.9M$22.74M$4.68M$5.32M$4.14M$2.59M$1.09M$1.3M$640K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$170.09M$148.72M$106.96M$96.99M$83.77M$71.01M$64.92M$35.7M$15.13M$14.53M$12.07M$7.53M$4.76M$3.72M$2.22M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$1.62M$1.59M$1.58M$1.17M$1.17M$1.15M$751K$658K$658K$535K$475K$471K$361K$360K$257K
Retained Earnings-$26.77M-$76.12M-$44.35M-$63.73M-$52.51M-$37.53M-$56.88M-$33.9M-$29.21M-$24.44M-$19M-$10.68M-$9.1M-$5.96M-$5.86M
Comprehensive Income & Other-$420.23M-$348.02M-$308.43M-$253.14M-$204.24M-$170.39M-$116.9M-$87.9M-$60.64M-$39.59M-$22.75M-$13.76M-$4.84M$431K-$10.79M
Other Stockholders' Equity-$69.24M$1.12M$40.71M$32.34M$81.27M$115.1M$54M$49.16M$77.62M$43.35M$35.96M$44.07M$12.29M$17.55M$6.64M
Total Equity-$94.38M-$73.4M-$2.06M-$30.21M$29.93M$78.73M-$2.13M$15.91M$49.07M$19.44M$17.44M$33.87M$3.55M$11.95M$1.03M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$75.7M$75.32M$104.9M$66.77M$113.7M$149.74M$62.79M$51.61M$64.2M$33.97M$29.51M$41.4M$8.31M$15.67M$3.25M
Supplementary Data
Total Debt$106.49M$56.87M$56.49M$59.4M$51.41M$54.72M$49.74M$22.93M$5.28M$6.33M$5.14M$2.6M$1.24M$1.6M$919K
Net Debt$47.56M$1.3M-$27.61M$13.16M-$42.34M-$78.4M$10.54M-$17.52M-$47.46M-$17.19M-$13.86M-$34.26M-$4.35M-$12.21M-$85K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$26.77M-$76.12M-$44.35M-$63.73M-$52.51M-$37.53M-$56.88M-$33.9M-$29.21M-$24.44M-$19M-$10.68M-$9.1M-$5.96M-$5.86M
Depreciation & Amortization$1.67M$1.81M$1.69M$1.68M$1.74M$1.96M$1.97M$692K$546K$539K$510K$344K$261K$164K$221K
Deferred Income Tax$3K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$3.95M$4.8M$3.69M$3.55M$3.58M$3.27M$4.83M$2.09M$2.91M$2.22M$1.44M$282K$668K$504K$297K
Changes in Working Capital:
  Accounts Receivable$2.07M-$2.31M-$900K-$113K$69K-$57K-$95K$161K-$183K$84K-$88K-$830$502$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$5.87M$2.46M$490K-$564K-$5.32M$7.6M-$3.9M$336K$1.2M$374K-$3.18M-$569K-$636K$0$0
Total Working Capital Change-$3.8M$146K-$410K-$677K-$5.25M$7.55M-$4M$497K$1.01M$458K-$3.27M-$569K-$636K$0-$96K
Other Non-Cash Items-$12.4M$47.51M$25.45M$17.73M$19.07M-$6.01M$8.09M$1.6M$1.33M$797K$1.52M$1.05M$1.17M$1.6M-$5K
Net Cash from Operating-$37.34M-$21.84M-$13.94M-$41.45M-$33.37M-$30.77M-$45.99M-$29.03M-$23.4M-$20.43M-$18.79M-$9.57M-$7.63M-$4.2M-$5.44M
Investing Activities
Capital Expenditures-$601K-$945K-$366K-$103K-$255K-$107K-$1.22M-$465K-$1.5M-$447K-$1.67M-$1.08M-$219K-$51K$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$91K
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$5.62M
Other Investing Activities-$45K-$122K-$23K$257K-$16K-$18K-$411K$544K-$250K-$50K-$794K-$200K$4K-$5K$0
Net Cash from Investing-$646K-$1.07M-$390K$154K-$270K-$125K-$1.63M$79K-$1.75M-$497K-$2.46M-$1.28M-$215K-$55K$5.53M
Financing Activities
Debt Repaid-$42.66M$4.64M$4.04M$5.29M$4.18M-$10.25M-$13.89M-$16.84M$1.15M-$1.37M-$2.56M-$1.33M$408K--$169K
Common Stock Issuance$1.71M$0$0$0$0$0$0$0$0$0$0$0$0$0$16K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0-$8K$0-$2.11M-$1.24M$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$2.58M-$1.09M$56.29M-$1.02M-$1.61M$114.62M$32.46M-$249K$55.39M$24.21M$862K$40.8M$2.11M$17.06M$13K
Net Cash from Financing$41.8M-$5.74M$52.25M-$6.31M-$5.79M$124.87M$46.35M$16.59M$54.24M$25.58M$3.41M$42.13M-$400K$17.06M$198K
Forex Effect-$449K$105K-$57K$93K$72K-$70K$32K$60K$131K-$125K-$15K-$587$0$0$0
Net Change in Cash$3.37M-$28.54M$37.87M-$47.52M-$39.36M$93.91M-$1.24M-$12.3M$29.22M$4.53M-$17.86M$36.85M$5.56M$13.81M$279K
Supplementary Data
Operating Cash Flow-$37.34M-$21.84M-$13.94M-$41.45M-$33.37M-$30.77M-$45.99M-$29.03M-$23.4M-$20.43M-$18.79M-$9.57M-$7.63M-$4.2M-$5.44M
Capital Expenditure-$610K-$945K-$366K-$103K-$255K-$107K-$1.22M-$465K-$1.5M-$447K-$1.67M-$1.08M-$219K-$51K$0
Free Cash Flow-$37.95M-$22.79M-$14.3M-$41.55M-$33.63M-$30.87M-$47.21M-$29.5M-$24.9M-$20.87M-$20.46M-$10.64M-$7.85M-$4.25M-$5.44M
Cash at Beginning$55.57M$84.11M$46.24M$93.76M$133.12M$39.21M$40.45M$52.75M$23.53M$19M$36.85M$0$0$0$725K
Cash at End$58.93M$55.57M$84.11M$46.24M$93.76M$133.12M$39.21M$40.45M$52.75M$23.53M$19M$36.85M$5.56M$13.81M$1M